Clinical effect of spleen aminopeptide on improving liver function damage and immune function in children with infant hepatitis syndrome

Table 1 Comparison of general data between the two groups (n, mean ± SD)

Group	Average age (d)	The average course of disease (d)	Patient weight (kg)	First symptoms
				Jaundice	Pneumonia	Diarrhea
Control group (50)	41.78 ± 4.32	11.34 ± 3.25	3.34 ± 0.25	36	8	6
Therapy group (50)	41.62 ± 4.66	11.31 ± 3.64	3.31 ± 0.64	35	10	5
χ2/t	0.169	0.043	-0.309	0.327
P value	0.866	0.965	0.758	0.849